Carlos L Arteaga

30PUBLICATIONS
232CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 11, 2026
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.

|Jan 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Niamh Coleman, Zihan Wei, A John Iafrate

|Oct 16, 2025
Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life.

Kelley Newcomer, Alessandro Bifolco, Sarah Reeves

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Jun 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K.

Carolyn K McCourt, Zihan Wei, Kevin Kalinsky

|May 19, 2025
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131).

Mohamed A Gouda, Filip Janku, Ying Yuan

Pageof 5

Frequent Collaborators

9 joint publications

Ariella B Hanker

8 joint publications

Lyndsay N Harris

8 joint publications

Peter J O'Dwyer

8 joint publications

Keith T Flaherty